Systematic isolation of genes encoding candidate proteins for human melanoma antigens using serial analysis of gene expression (SAGE) and EST database
Systematic isolation of genes encoding candidate proteins for human melanoma antigens using serial analysis of gene expression (SAGE) and EST database
批准号:
12470180
负责人:
KAWAKAMI Yutaka
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
To identify genes preferentially expressed in melanocyte / melanoma, we have applied two methods; comparison of cDNA profiles generated by serial analysis of gene expression (SAGE) and of EST databases from various tissues. AcDNA profile of highly pigmented melanoma cell line SKme123 was first evaluated using SAGE. 25,997 tags consisting of 10,382 transcripts were sequenced. This melanoma SAGE library was compared to SAGE databases from normal tissues including brain, colon and testis, brain and colon cancers, and also compared to the melanocyte cDNA library. Two tags possibly encoding new melanocyte specific genes with relatively high frequency were identified, and their specific expression was confirmed by RT-PCR and Northern blot analysis. Full length clones of these sequences were isolated from the SKme123 λ phage. One was a splicing variant of TRP2; the other was a novel gene with unknown function. In the next study, by comparing EST databases from various tissues using computer, 80 possibly melanocyte specific genes were selected, then, their expression was evaluated using RT-PCR. Seven sequences were found to express only in melanocytes or melanoma, and the isolation of the full length cDNA were attempted. M43 was a splicing variant of AMI, previously identified melanoma antigen recognized by T cells. M44 encoded a novel melanocyte specific molecule. M125 was a splicing variant of Melastatin 1, a possible tumor marker for melanoma. M40, M109 and M674 were found to be a3'-sequence of the novel melanocyte specific gene. M216 may also have a novel melanocyte specific gene at its 5'-upstream. Therefore, melanocyte / melanoma specific genes can be systematically isolated using SAGE and EST databases. These melanocyte specific genes may be useful for research on biology of melanocytes as well as development of diagnostic and therapeutic methods for disorder of pigmentation and melanoma.
期刊论文(51)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kuwana M, Kawakami, Y., et al.: "Induction of antigen-specific human CD4+ T cell anergy by peripheral blood DC2 precursors"Eur.J.Immunol.. 31・9. 2547-2557 (2001)
Kuwana M,Kawakami,Y.等人:“外周血DC2前体诱导抗原特异性人CD4+T细胞无反应性”Eur.J.Immunol.. 31·9(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kuwana M, Kawakami Y, et al.: "Induction of antigen-specific human CD4+ T cell anergy by peripheral blood DC2 precursors"Eur. J. Immunol. 31・9. 2547-2557 (2001)
Kuwana M、Kawakami Y 等:“外周血 DC2 前体诱导抗原特异性人 CD4+ T 细胞无反应性”Eur. J.Immunol. 2547-2557 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawakami Y. et al.: "T cell responses to melanoma and melanocytes."Pigment Cell Research. 13. 163-169 (2000)
Kawakami Y. 等人:“T 细胞对黑色素瘤和黑色素细胞的反应。”色素细胞研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kuwana M. et al.: "Induction of antigen-specific human CD4+ T cell anergy by peripheral blood DC2 precursors"Eur. J. Immunol.. 31 (9). 2547-2557 (2001)
Kuwana M.等人:“外周血DC2前体诱导抗原特异性人CD4 T细胞无反应性”Eur。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Investigation of differential immune status among cancer patients and development of personalized cancer therapy by combining immunomodulation
-
批准号:26221005
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$124.88万
-
财政年份:2014
-
负责人:KAWAKAMI Yutaka
-
依托单位:
Systematic analysis of cellular signaling involved in the melanoma induced immunosuppression
-
批准号:25670506
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:KAWAKAMI Yutaka
-
依托单位:
Development of effective immunotherapy by combining interventions on key points in the anti-tumor immune network
-
批准号:23240128
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.37万
-
财政年份:2011
-
负责人:KAWAKAMI Yutaka
-
依托单位:
Investigation of roles of miRNA in the immunosuppression and clinical use for patients with melanoma
-
批准号:23659554
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:KAWAKAMI Yutaka
-
依托单位:
Development of effective immunotherapy by combining methods to restore immunocompetence of cancer patients
-
批准号:19390355
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2007
-
负责人:KAWAKAMI Yutaka
-
依托单位:
Development of immunotherapy based on the identification of tumor antigens
-
批准号:17016070
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$34.69万
-
财政年份:2005
-
负责人:KAWAKAMI Yutaka
-
依托单位:
Development of new diagnostic and immunotherapeutic methods for patients with cancer
-
批准号:14104013
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$70.14万
-
财政年份:2002
-
负责人:KAWAKAMI Yutaka
-
依托单位:
Development of diagnositic and therapeutic methods using frameshift mutated peptides for colorectal cancers with microsatellite instability
-
批准号:12557109
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:2000
-
负责人:KAWAKAMI Yutaka
-
依托单位:
Isolation of human melanoma antigens recognized bt T cells for development of immunotherapy and gene therapy
-
批准号:10557083
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:1998
-
负责人:KAWAKAMI Yutaka
-
依托单位:
Isolation of human tumor antigens recognized by antibodies for development of immunotherapy and gene therapy
-
批准号:10470264
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.38万
-
财政年份:1998
-
负责人:KAWAKAMI Yutaka
-
依托单位:
海外基金